Lei Yin
- Hepatology top 2%
- Surgery
- Molecular Biology
- Cancer Research top 10%
- Epidemiology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (8 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)RNA modifications and cancer (4 papers)
- Cited by
- HepatologyCancer ResearchAging
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Lei Yin
25 papers receiving 603 citations
Peers
Comparison fields: 5 of 58
- Hepatology 319
- Surgery 192
- Molecular Biology 172
- Cancer Research 166
- Epidemiology 156
Countries citing papers authored by Lei Yin
This map shows the geographic impact of Lei Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yin more than expected).
Fields of papers citing papers by Lei Yin
This network shows the impact of papers produced by Lei Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yin. The network helps show where Lei Yin may publish in the future.
Co-authorship network of co-authors of Lei Yin
This figure shows the co-authorship network connecting the top 25 collaborators of Lei Yin. A scholar is included among the top collaborators of Lei Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Yin. Lei Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 22 | |
| 4 | 9 | |
| 5 | 13 | |
| 6 | 0 | |
| 7 | 14 | |
| 8 | 15 | |
| 9 | 6 | |
| 10 | 31 | |
| 11 | 233 | |
| 12 | 11 | |
| 13 | 7 | |
| 14 | 66 | |
| 15 | 4 | |
| 16 | 11 | |
| 17 | 3 | |
| 18 | 11 | |
| 19 | 21 | |
| 20 | 20 |
About Lei Yin
Lei Yin is a scholar working on Hepatology, Cancer Research and Surgery, having authored 26 papers that have together received 612 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Hepatology (319 citations), Cancer Research (166 citations) and Aging (8 citations). Lei Yin has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Aijun Li, Weiping Zhou, Ze‐Ya Pan, Mengchao Wu, Wan Yee Lau, Eric C. H. Lai, Hui Li, Huan Chen, Mingyong Miao and Shengsheng Yang. Their work appears in journals such as FEBS Letters, Journal of Nutrition and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.